Antibody TF2

DRUG2 trials

Sponsors

Centre René Gauducheau, Nantes University Hospital

Conditions

CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)Metastatic Colorectal CancerSmall Cell Lung Cancer

Phase 1

TF2- Small Cell Lung Cancer Radio Immunotherapy

CompletedNCT01221675

Centre René GauducheauCEA-expressing Non Small Cell Lung Carcinoma (NSCLC), Small Cell Lung Cancer

Start: 2011-06-30End: 2016-04-30Updated: 2016-08-31

Pretargeted Radioimmunotherapy in Metastatic Colorectal Cancer

TerminatedNCT02300922

Nantes University HospitalMetastatic Colorectal Cancer

Start: 2015-01-27End: 2017-12-20Updated: 2022-08-01

Related Papers

Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients.

2015-11-2723 citations